| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JAZZ | Ordinary Shares | Award | $0 | +5.09K | +17.37% | $0.00 | 34.4K | Jan 17, 2024 | Direct | F1, F2 |
| transaction | JAZZ | Ordinary Shares | Tax liability | -$197K | -1.66K | -4.82% | $119.13 | 32.7K | Jan 17, 2024 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified. |
| F2 | The Reporting Person acquired 96 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023. |
| F3 | Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations. |